|23.84||-0.18 / -0.75%|
Data as of 3:59pm ET
|23.84||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 34.00, with a high estimate of 51.00 and a low estimate of 26.00. The median estimate represents a +42.62% increase from the last price of 23.84.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.